2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAntiobesity Market?

Obesity remains a critical global health challenge, with its prevalence rising consistently each year. According to the World Obesity Atlas, published in May 2022 by a UK-based organization, over 1 billion people worldwide are projected to be living with obesity by 2030. This surge is driven by factors such as increased intake of unhealthy and processed foods, sedentary lifestyles, and low awareness regarding the health risks associated with obesity. Consequently, the growing need for anti-obesity treatments is expected to drive the expansion of the anti-obesity drugs market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp

#What is the Anticipated CAGR of theAntiobesity Market, and What Factors Will Drive It?

The antiobesity market has seen rapid expansion in recent years. It is expected to rise from $3.74 billion in 2024 to $4.15 billion in 2025, with a CAGR of 11.1%. Past growth has been fueled by the increasing prevalence of obesity, educational efforts, lifestyle changes, and government-supported initiatives.

The antiobesity market is expected to see rapid growth, reaching $6.08 billion by 2029 at a CAGR of 10.0%. Growth drivers include market expansion and globalization. Trends include research and development, patient-centric approaches, insurance coverage, technological advancements, digital health, telemedicine, new drug therapies, bariatric surgery innovations, over-the-counter solutions, and behavioral interventions.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3403

What Are the Current Market Growth and Trends in theAntiobesity Market That Industry Players Should Watch?

Major players in the anti-obesity drugs market are innovating treatments like Mounjaro (tirzepatide) to support weight loss in patients with obesity and related conditions. Approved by the FDA, Mounjaro, launched by Eli Lilly and Company in October 2022, is an injectable medication used in conjunction with diet and exercise to manage type 2 diabetes and promote weight reduction.

What Are the Major Market Players Making an Impact on theAntiobesity Market Growth?

Major companies operating in the antiobesity market include F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Novartis International AG, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Allergan Aesthetics, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Intas Pharmaceuticals Ltd., Wockhardt Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report

How Are the Key Segments of the Antiobesity Market Driving Opportunities and Innovations?

The antiobesity market covered in this report is segmented –

1) By Drug Class: Peripherally Acting Anti-Obesity Drugs, Centrally Acting Anti-Obesity Drugs

2) By Type: Prescription Drugs (Rx), OTC Drugs

3) By Medication: Monotherapies, Polytherapies

Subsegments:

1) By Peripherally Acting Anti-Obesity Drugs: Orlistat, Lorcaserin

2) By Centrally Acting Anti-Obesity Drugs: Phentermine, Topiramate, Naltrexone-Bupropion Combination, Liraglutide

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3403&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAntiobesity Market?# Market Expansion?

North America was the largest region in the anti-obesity market in 2023. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Antiobesity Market 2025, By The Business Research Company:

Hormonal Contraceptives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Organ-On-Chip Global Market Opportunities And Strategies To 2021

https://www.thebusinessresearchcompany.com/report/organ-on-chip-market

Medical Foods Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-foods-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: